Time is brain: for every minute a stroke is left untreated, 2 million brain cells are destroyed. The sooner patients are treated, the higher the chances of survival with fewer disabilities. Patients with acute strokes and transient ischemic attack (TIA) are assessed and treated at the right place, the right time and by the right professionals thanks to ultra-specialized stroke centres at the Montreal General Hospital and The Montreal Neurological Institute and Hospital.
Researchers pinpoint a brain area that influences electoral decisions
As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn more about the disease and current research and treatments, to donate money for ALS research and to wear the national emblem of ALS in Canada, the blue cornflower, during ALS Awareness Month in June.
Today the Honourable Ed Holder, Minister of State (Science and Technology) announced an investment of $333 million for research infrastructure through the Canada Foundation for Innovation (CFI). Two projects submitted by researchers affiliated with the Montreal Neurological Institute and Hospital – The Neuro at McGill University and the MUHC, have received a total of over $21 M in funding, with matching funds from the Government of Quebec.
Public lecture: Perspectives on bilingualism: From birth to aging Living in a city with many languages, we are often confronted with personal debates about what are the best decisions to make for our children and for ourselves. Have you wondered when is the optimal time and in what way to introduce a second language to your child, or whether raising a child in a bilingual environment can create confusion? Have you heard that being bilingual might slow down cognitive decline in aging and provide a buffer against neurodegenerative disease?
Montreal Neurological Institute scientists discover a new mechanism driving spread of cancer A protein commonly found in human cells could be an important switch that activates cancer cell metastasis, according to a new study by researchers at the Montreal Neurological Institute and Hospital - The Neuro at McGill University and the MUHC. The finding focuses attention on a biological mechanism that until now was largely overlooked. The discovery of the protein’s effect significantly expands our understanding of epithelial cancers such as breast and lung cancer.
<p>October is Brain Tumour Awareness Month</p>
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes.
Dr. Brenda Milner, an active researcher at the age of 95 at the Montreal Neurological Institute and Hospital - The Neuro, McGill University, is a recipient of The 2014 Kavli Prize in Neuroscience.
Timing is everything: scientists control rapid re-wiring of brain circuits using patterned visual stimulation
In a new study, published in this week’s issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli. In most neuroscience textbooks today, there is a widely held model that explains how nerve circuits might refine their connectivity based on patterned firing of brain cells, but it has not previously been directly observed in real time.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and McGill University Health Centre, is being awarded the Prix d’excellence 2014 by the Collège des médecins du Québec, for his outstanding contributions to neurogenetics and medicine. Dr. Rouleau accepts the award today at a ceremony at the Chateau Frontenac in Quebec City. TRIBUTE VIDEO: http://bit.ly/1np0tJH
People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation.
The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease. New Rapid-Access Clinic at The Neuro reduces wait time
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The “Montreal Procedure” developed by Dr. Wilder Penfield and colleagues revolutionized the surgical treatment for epilepsy, allowing thousands of patients to start new lives free of seizures. The use of electroencephalography (EEG) and magnetic resonance imaging (MRI) for the study and treatment of epilepsy was pioneered at The Neuro.
Montreal scientists play key role in long-term international study Rate of change in the thickness of the brain’s cortex is an important factor associated with a person’s change in IQ, according to a collaborative study by scientists in five countries including researchers at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the McGill University Health Centre.